Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Int J Oral Maxillofac Surg ; 46(5): 655-661, 2017 May.
Article in English | MEDLINE | ID: mdl-28209379

ABSTRACT

The continuous presence of recombinant human bone morphogenetic protein 2 (rhBMP-2) inside a scaffold may be crucial to the outcome in bone tissue engineering. This study investigated whether the release of the growth factor rhBMP-2 via different continuous application schemes influences histomorphological aspects of the hard and soft tissues induced. Three-dimensionally printed hydroxyapatite scaffolds were implanted into one latissimus dorsi muscle of 42 female Lewis rats. Simultaneously implanted mini-osmotic pumps were used to provide a continuous application of rhBMP-2 over 1, 2, or 4 weeks (total dose 200µg). A reference group received rhBMP-2 at the time of implantation only, and a control group received only block implantation. Bone density and histological examinations were performed after 8 weeks. No significant difference in bone density was found between the groups; however, the blood vessel count differed significantly between the groups receiving continuous treatments and both the control group and simultaneous rhBMP-2 treatment group (P<0.0001). Soft tissue types were distributed differently among the study groups. RhBMP-2 application via mini-osmotic pumps is as suitable for inducing bone formation as a single application at the time of implantation. The time interval over which rhBMP-2 was administered had no impact on the amount of new bone formation, probably due to the study duration and low local concentrations of growth factor.


Subject(s)
Bone Morphogenetic Protein 2/pharmacology , Drug Delivery Systems , Osteogenesis/drug effects , Tissue Engineering/methods , Transforming Growth Factor beta/pharmacology , Animals , Biological Availability , Bone Density , Durapatite/pharmacology , Female , Models, Animal , Osmosis , Rats , Rats, Inbred Lew , Recombinant Proteins/pharmacology , Tissue Scaffolds
2.
Clin Lab ; 61(1-2): 61-8, 2015.
Article in English | MEDLINE | ID: mdl-25807639

ABSTRACT

BACKGROUND: The aim of the study was to examine the in vitro antibacterial activity of different oils in comparison to antiseptics against oral microorganisms. METHODS: The antimicrobial effect of tea tree oil (TTO), eucalyptus oil (EO), lemon grass oil (LGO), and a eucalyptus-based oil mixture (MXT) were tested in comparison to chlorhexidine digluconate (CHX), povidone-iodine (BTA), and octenidine dihydrochloride (OCT). Oral bacterial strains and candida species using the agar diffusion test were used for the antimicrobial study. RESULTS: All tested oils showed antimicrobial potency against the tested biological indicators. In comparison of all tested substances the largest effective zones were measured for LGO, followed from MXT and CHX. TTO and EO were less effective against the tested microorganisms followed from BTA. CONCLUSIONS: The results of this study show that some essential oils have better antimicrobial properties than standard oral antiseptics. In a follow-up step, the ideal concentrations, the composition of essential oils, and the mode of application will be evaluated. The antibacterial efficacy of essential oils might be promising for use in clinical and oral hygiene applications. The cost reduction and availability particularly in rural areas with easy access to the originating plants might be advantageous factors to be considered.


Subject(s)
Anti-Infective Agents , Eucalyptus , Microbial Sensitivity Tests , Oils, Volatile , Oral Hygiene , Plant Oils , Terpenes , Australia , Eucalyptus Oil , Humans , Monoterpenes , Mouth/microbiology
3.
Int J Oral Maxillofac Surg ; 41(9): 1153-60, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22652448

ABSTRACT

When bone morphogenetic protein (BMP) is delivered to matrices in vivo may affect tissue engineered bone constructs for jaw reconstruction after cancer surgery. This study compared the effects of BMP application at different times after matrix implantation for heterotopic bone induction in a rat model. Hydroxyapatite blocks were implanted unilaterally onto the surface of the latissimus dorsi muscle. A second block was implanted onto the contralateral muscle after 1, 2 or 4 weeks and 200 µg rhBMP-2 was injected into the blocks on both sides. Bone formation and density inside the blocks was analysed by CT and histology. 8 weeks after BMP application increases in bone density within the scaffolds were most pronounced in the simultaneous application group (179 HU). Less pronounced increases were observed for the 1 (65 HU), 2 (58 HU) and 4 (31 HU; p<0.0001) week delay group. Homogeneous bone induction started from the central channel of the blocks. Capillaries and larger vessels were seen in all constructs, samples receiving delayed BMP treatment demonstrated significantly greater neovascularization. Delayed application of BMP was less effective for heterotopic bone formation than simultaneous application. A central channel allows homogeneous bone induction directly from the centre of the blocks.


Subject(s)
Bone Morphogenetic Protein 2/administration & dosage , Bone Substitutes/administration & dosage , Hydroxyapatites/administration & dosage , Osteogenesis/drug effects , Tissue Engineering/methods , Absorbable Implants , Animals , Bone Matrix , Drug Administration Schedule , Drug Delivery Systems , Female , Implants, Experimental , Osseointegration/drug effects , Rats , Rats, Inbred Lew , Time Factors , Tissue Scaffolds
4.
Physiol Res ; 60(5): 797-813, 2011.
Article in English | MEDLINE | ID: mdl-21812519

ABSTRACT

Poly-(lactide-co-glycolide) (PLGA) is an FDA-approved biodegradable polymer which has been widely used as a scaffold for tissue engineering applications. Collagen has been used as a coating material for bone contact materials, but relatively little interest has focused on biomimetic coating of PLGA with extracellular matrix components such as collagen and the glycosaminoglycan chondroitin sulfate (CS). In this study, PLGA films were coated with collagen type I or collagen I with CS (collagen I/CS) to investigate the effect of CS on the behaviour of the osteoblastic cell line MG 63. Collagen I/CS coatings promoted a significant increase in cell number after 3 days (in comparison to PLGA) and after 7 days (in comparison to PLGA and collagen-coated PLGA). No influence of collagen I or collagen I/CS coatings on the spreading area after 1 day of culture was observed. However, the cells on collagen I/CS formed numerous filopodia and displayed well developed vinculin-containing focal adhesion plaques. Moreover, these cells contained a significantly higher concentration of osteocalcin, measured per mg of protein, than the cells on the pure collagen coating. Thus, it can be concluded that collagen I/CS coatings promote MG 63 cell proliferation, improve cell adhesion and enhance osteogenic cell differentiation.


Subject(s)
Cell Engineering/methods , Chondroitin Sulfates/pharmacology , Collagen Type I/pharmacology , Lactic Acid/chemistry , Osteoblasts/drug effects , Osteoblasts/physiology , Osteogenesis/physiology , Polyglycolic Acid/chemistry , Cell Line , Cell Proliferation/drug effects , Cell Survival/drug effects , Cells, Cultured , Chondroitin Sulfates/chemistry , Coated Materials, Biocompatible/chemistry , Coated Materials, Biocompatible/pharmacology , Collagen Type I/chemistry , Humans , Materials Testing , Osteoblasts/cytology , Osteogenesis/drug effects , Polylactic Acid-Polyglycolic Acid Copolymer , Tissue Scaffolds
5.
J Craniomaxillofac Surg ; 39(1): 54-64, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20434921

ABSTRACT

The most promising attempts to achieve bone regeneration artificially are based on the application of mediators such as bone morphogenetic proteins (BMPs) directly to the deficient tissue site. BMPs, as promoters of the regenerative process, have the ability to induce de novo bone formation in various tissues, and many animal models have demonstrated their high potential for ectopic and orthotopic bone formation. However, the biological activity of the soluble factors that promote bone formation in vivo is limited by diffusion and degradation, leading to a short half-life. Local delivery remains a problem in clinical applications. Several materials, including hydroxyapatite, tricalcium phosphate, demineralised bone matrices, poly-lactic acid homo- and heterodimers, and collagen have been tested as carriers and delivery systems for these factors in a sustained and appropriate manner. Unfortunately these delivery vehicles often have limitations in terms of biodegradability, inflammatory and immunological rejection, disease transmission, and most importantly, an inability to provide a sustained, continuous release of these factors at the region of interest. In coping with these problems, new approaches have been established: genes encoding these growth factor proteins can be delivered to the target cells. In this way the transfected cells serve as local "bioreactors", as they express the exogenous genes and secrete the synthesised proteins into their vicinity. The purpose of this review is to present the different methods of gene versus growth factor delivery in tissue engineering. Our review focuses on these promising and innovative methods that are defined as regional gene therapy and provide an alternative to the direct application of growth factors. Various advantages and disadvantages of non-viral and viral vectors are discussed. This review identifies potential candidate genes and target cells, and in vivo as well as ex vivo approaches for cell transduction and transfection. In explaining the biological basis, this paper also refers to current experimental and clinical applications.


Subject(s)
Bone Regeneration/physiology , Genetic Therapy , Intercellular Signaling Peptides and Proteins/therapeutic use , Bone Regeneration/genetics , Drug Delivery Systems , Forecasting , Gene Transfer Techniques , Genetic Vectors , Humans , Tissue Engineering/methods
6.
Oral Maxillofac Surg ; 12(1): 39-41, 2008 May.
Article in English | MEDLINE | ID: mdl-18600360

ABSTRACT

INTRODUCTION: Bite wounds of the oral mucosa heal after eliminating the causative irritant, but there are serious exceptions from the rule. We present the case of a 37-year-old woman with an ulcer of the mucosa of the lower lip, which had been present for 10 days, and leucopenia. DISCUSSION: Agranulocytosis after the use of metamizole is part from leukaemia and lues, a rare reason for non-healing ulcers of the mucosa of the oral cavity without fulminant signs for inflammation. CONCLUSION: As this is a life-threatening disease, medical therapy must begin immediately.


Subject(s)
Agranulocytosis/chemically induced , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Dipyrone/adverse effects , Adult , Agranulocytosis/drug therapy , Bites, Human/complications , Chronic Disease , Female , Granulocyte Colony-Stimulating Factor/therapeutic use , Humans , Lip Diseases/etiology , Lip Diseases/physiopathology , Oral Ulcer/etiology , Oral Ulcer/physiopathology , Recombinant Proteins , Wound Healing
7.
Int J Oral Maxillofac Surg ; 36(6): 527-32, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17418531

ABSTRACT

Chronic infections of bone such as osteomyelitis are frequent events, especially in immunocompromised or diabetic patients, and costly on a national level. Incorrect treatment or delayed diagnosis may lead to loss of the affected extremity or mandible. The aim of this study was to assess the possible value of urinary lysylpyridinoline (LP) and hydroxylysylpyridinoline (HP) concentrations in the monitoring of mandibular osteomyelitis. Patients were assigned to the following groups: group 1 (n=85), control; group 2a (n=38), patients with active disease; group 2b (n=25), patients of group 2a 6 months after successful treatment; group 2c (n=7), patients of group 2a with ongoing osteomyelitis 6 months after treatment. The range and upper limit of normal values (HP(max) and LP(max)) were determined in group 1. Levels of LP and HP were measured by high-performance liquid chromatography and fluorescence detection. There was a significant decrease (mean 45.43% for HP and 32.12% for LP) in samples of group 2b compared to 2a (P<0.001 for HP and LP). There was a significant increase in HP values in samples from group 2c compared to 2a (P=0.018). The urinary concentrations of HP and LP appear to act as a marker of disease activity, with a decrease reflecting treatment success and an increase or stable values indicating persistent disease. An inexpensive tool (US$5 per analysis) for the monitoring of osteomyelitis is described.


Subject(s)
Amino Acids/urine , Mandibular Diseases/urine , Osteomyelitis/urine , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers/urine , Chromatography/methods , Epidemiologic Methods , Female , Fluorescence , Humans , Male , Mandibular Diseases/diagnosis , Mandibular Diseases/surgery , Middle Aged , Osteomyelitis/diagnosis , Osteomyelitis/surgery , Recurrence , Sex Factors
8.
Int J Oral Maxillofac Surg ; 36(5): 386-90, 2007 May.
Article in English | MEDLINE | ID: mdl-17418534

ABSTRACT

Selective reduction of bone without collateral damage (nerves, teeth) is essential in apicectomy. To test whether skills acquired on a virtual apicectomy simulator (VOXEL-MAN system with integrated force-feedback) are transferable from virtual to physical reality, two groups of trainees were compared. Group 1 received computer-based virtual surgical training before performing an apicectomy in a pig cadaver model. The probability of preserving vital neighboring structures was improved significantly, i.e. six-fold, after virtual surgical training (P<0.001). The average volume of the bony defects created by the trainees of Group 2 (mean: 0.47 ml) was significantly (P<0.001) larger than by the trainees of Group 1 (mean: 0.25 ml). Most importantly, the ability to objectively self-assess performance was significantly improved after virtual training. Training with a virtual apicectomy simulator appears to be effective, and the skills acquired are transferable to physical reality.


Subject(s)
Apicoectomy , Computer Simulation , Learning , Surgery, Oral/education , User-Computer Interface , Alveolectomy , Animals , Clinical Competence , Feedback , Humans , Intraoperative Complications , Mandibular Nerve/pathology , Motor Skills , Self-Assessment , Swine
9.
Phytomedicine ; 13(7): 463-7, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16785038

ABSTRACT

Malodorous necrotic ulcers in cancer patients are of major concern as it leads to social isolation and poor quality of life. Current medications and topical therapies have proven inadequate in their ability to reduce foul smell to acceptable levels. We report the positive experience we have had in using antibacterial essential oils in patients with incurable head and neck cancer and associated malodorous necrotic ulcers. All patients received a standard course of therapy with oral or systemic antibiosis. In addition, we rinsed the ulcers with an antibacterial essential oil mix (mainly based on Eucalyptus oil) twice a day. All patients experienced complete resolution of the foul smell by only the third or fourth day of therapy. As a secondary effect we saw that besides smell reduction the oils had anti-inflammatory effects on neoplastic ulcers. In some patients ulcers started to heal and achieved complete re-epithiliazation. The patients experienced great personal relief upon resolution of their malodorous conditions. Quality of life improved significantly with the resulting reintroduction of social contact with friends and relatives.


Subject(s)
Carcinoma, Squamous Cell/complications , Eucalyptus , Head and Neck Neoplasms/complications , Odorants/prevention & control , Plant Oils/therapeutic use , Skin Ulcer/drug therapy , Aged , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/pathology , Female , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/pathology , Humans , Male , Middle Aged , Necrosis/drug therapy , Quality of Life , Skin Ulcer/etiology , Skin Ulcer/pathology
10.
J Cutan Pathol ; 33(2): 175-80, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16420315

ABSTRACT

The sebaceous nevus syndrome describes the rare association of a sebaceous nevus with systemic features such as mental retardation, seizures and colobomas (among others). It is thought to be a cutaneous mosaic inherited as a paradominant trait. Three cases are provided illustrating the intraoral manifestations of the syndrome. The first histological comparison of contiguous mucosal and cutaneous lesions is provided. We also describe the possible association of SFM syndrome with a benign fibrous histiocytic lesion of the mandible. This and other mandibular tumors associated with the sebaceous nevus syndrome may have significant implications for patients. Awareness of the potential presence or development of significant intraoral lesions in association with the sebaceous nevus syndrome is important for those involved in the care of patients with this syndrome.


Subject(s)
Mouth Mucosa/pathology , Nevus/complications , Abnormalities, Multiple/pathology , Child , Female , Humans , Male , Mouth Neoplasms/etiology , Mouth Neoplasms/pathology , Nevus/pathology , Papilloma/etiology , Papilloma/pathology
11.
Bone ; 38(3): 400-8, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16263346

ABSTRACT

Bone has exceptional regenerative properties. Oral bone appears to be particularly resistant to infection despite exposure to oral flora, even in circumstances such as oral surgery where the thin mucosal layer covering the bone is disrupted. The goal of this study was to determine whether the innate immune system of antimicrobial peptides exists inside bone. Biopsies of non-infected and chronically infected mandibular bone were harvested from patients during maxillofacial surgical procedures. Bone biopsies from the iliac crest and fibula served as controls. Immunohistochemical staining was performed, directed against the human beta-defensin antimicrobial peptides (hBD) -1, -2 and -3. In addition, cultures of osteoblast-like cells were examined for the presence of each of the three beta-defensins and their mRNA transcripts. All three human beta-defensins were detected within the mineralized bone matrix of chronically infected mandibular bone in the vicinity of the endosteum and osteocytes. hBD-1, -2 and -3 were also found in the cytoplasm of osteocytes. Expression of all three beta-defensins was detected in each of the non-infected bone types including the controls, however, to a lesser degree than that found in the chronically infected mandibular bone. This may reflect upregulation of antimicrobial peptide expression in the presence of chronic infection. Cultures of non-infected osteoblast-like cells were found to express mRNA for each of hBD-1, -2 and -3. Immunohistochemical staining of the cultures was positive for hBD-1 and -2, but not for hBD-3. We provide the first evidence of a previously unrecognized innate immunological function of bone through the demonstration of the presence of the human beta-defensins hBD-1, -2 and -3 in bone.


Subject(s)
Antimicrobial Cationic Peptides/immunology , Immunity, Innate , beta-Defensins/immunology , Alkaline Phosphatase/metabolism , Antimicrobial Cationic Peptides/metabolism , Biomarkers/metabolism , Biopsy , Cell Culture Techniques , Cells, Cultured , Culture Media/chemistry , Humans , Immunohistochemistry , Mandible/cytology , Osteoblasts/cytology , Osteoblasts/immunology , Osteoblasts/metabolism , Osteocalcin/biosynthesis , beta-Defensins/metabolism
12.
Mund Kiefer Gesichtschir ; 9(4): 257-62, 2005 Jul.
Article in German | MEDLINE | ID: mdl-15926085

ABSTRACT

BACKGROUND: Occasionally, trivial odontogenic infections may develop into complex diseases. This may even result in an unrestrained phlegmonous spread causing life-threatening complications. These problems have decreased since the introduction of antibiotics and also due to improved oral hygiene and improved diagnostic measures resulting in optimized medical treatment. However, life-threatening forms are still seen, in particular if infections spread along the cervical fascial sheaths down towards to the mediastinum. Over the past decade the number of critical infections has increased in other medical specialties. This is usually explained by the development of multiresistant pathogens in the context of nosocomial infections. PATIENTS AND METHODS: We reviewed the patients' records of the past 15 years at the Department of Oral and Maxillofacial Surgery of the University Hospital Kiel to assess a possible increase of odontogenic infections with life-threatening complications. From 1990 to 2004, four patients with odontogenic infections exhibiting critical phlegmonous spread were treated in the intensive care unit. Two patients developed bacterial mediastinitis which could be controlled by intravenous antibiotics only. One patient progressed to general septic mediastinitis and eventually died of cardiorespiratory arrest. The last patient also had septic mediastinitis and developed right pleural empyema. Several operations were necessary before the disease could be controlled. This patient's case report is presented in detail. CONCLUSION: The prognosis of patients with mediastinitis crucially depends on (a) early diagnosis including computed tomography of the neck and thorax, (b) early radical surgical intervention, and (c) optimized pathogen-oriented antibiotic treatment.


Subject(s)
Cellulitis/diagnostic imaging , Empyema, Pleural/diagnostic imaging , Mediastinitis/diagnostic imaging , Neck , Staphylococcal Infections/diagnostic imaging , Staphylococcus epidermidis , Streptococcal Infections/diagnostic imaging , Tomography, X-Ray Computed , Abscess/diagnostic imaging , Abscess/drug therapy , Abscess/surgery , Ampicillin/therapeutic use , Cefotaxime/therapeutic use , Cellulitis/drug therapy , Cellulitis/surgery , Combined Modality Therapy , Critical Care , Disease Progression , Empyema, Pleural/drug therapy , Empyema, Pleural/surgery , Follow-Up Studies , Humans , Male , Mediastinitis/drug therapy , Mediastinitis/surgery , Middle Aged , Neck/diagnostic imaging , Reoperation , Shock, Septic/diagnostic imaging , Shock, Septic/drug therapy , Shock, Septic/surgery , Staphylococcal Infections/drug therapy , Staphylococcal Infections/surgery , Streptococcal Infections/drug therapy , Streptococcal Infections/surgery , Sulbactam/therapeutic use , Therapeutic Irrigation , Thoracotomy , Vancomycin/therapeutic use
13.
Lancet ; 364(9436): 766-70, 2004.
Article in English | MEDLINE | ID: mdl-15337402

ABSTRACT

BACKGROUND: A major goal of research in bone transplantation is the ability to avoid creation of secondary bone defects. We aimed to repair an extended mandibular discontinuity defect by growth of a custom bone transplant inside the latissimus dorsi muscle of an adult male patient. METHODS: Three-dimensional computed tomography (CT) scanning and computer-aided design techniques were used to produce an ideal virtual replacement for the mandibular defect. These data were used to create a titanium mesh cage that was filled with bone mineral blocks and infiltrated with 7 mg recombinant human bone morphogenetic protein 7 and 20 mL of the patient's bone marrow. Thus prepared, the transplant was implanted into the latissimus dorsi muscle and 7 weeks later transplanted as a free bone-muscle flap to repair the mandibular defect. FINDINGS: In-vivo skeletal scintigraphy showed bone remodelling and mineralisation inside the mandibular transplant both before and after transplantation. CT provided radiological evidence of new bone formation. Postoperatively, the patient had an improved degree of mastication and was satisfied with the aesthetic outcome of the procedure. INTERPRETATION: Heterotopic bone induction to form a mandibular replacement inside the latissimus dorsi muscle in a human being is possible. This technique allows for a lower operative burden compared with conventional techniques by avoiding creation of a secondary bone defect. It also provides a good three-dimensional outcome.


Subject(s)
Mandible/surgery , Plastic Surgery Procedures/methods , Tissue Engineering/methods , Activin Receptors, Type I , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Cell Differentiation/drug effects , Humans , Imaging, Three-Dimensional , Male , Mandible/diagnostic imaging , Mandibular Neoplasms/surgery , Middle Aged , Osteogenesis , Postoperative Complications , Proteins/pharmacology , Radiography , Radionuclide Imaging , Surgical Flaps
14.
Phytomedicine ; 11(2-3): 95-7, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15070157

ABSTRACT

Multi-drug resistant strains of tuberculosis pose a serious threat in many third- and first-world countries. The aim of this case report is to describe a potential new method for treating those with primary pulmonary tuberculosis using phytochemicals via inhalation. We report the first case of using inhaled phytochemicals in treating primary pulmonary tuberculosis. A 28-year-old female presented with symptoms suggestive of primary pulmonary tuberculosis, and she was found to be positive via chest X-ray and sputum culture. She subsequently underwent treatment with conventional DOTS treatment. Ten days post-inhalation of the phytochemical, the patient is tuberculosis negative (via sputum culture), with no clinical symptoms. This may be a potential new method and type of treatment for pulmonary tuberculosis.


Subject(s)
Antitubercular Agents/therapeutic use , Eucalyptus , Phytotherapy , Plant Extracts/therapeutic use , Tuberculosis, Pulmonary/drug therapy , Administration, Inhalation , Adult , Antitubercular Agents/administration & dosage , Female , Humans , Plant Extracts/administration & dosage , Radiography , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Pulmonary/pathology
15.
J Cutan Pathol ; 30(7): 470-2, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12859747

ABSTRACT

The sebaceous nevus is a common nevus and can be easily diagnosed because of its typical rough fatty surface due to its amount of sebaceous glands. In some rare cases, the sebaceous nevus is part of a genetic disorder, the Schimmelpenning-Feuerstein-Mims (SFM) syndrome. If the SFM syndrome is suspected, further investigation is necessary, because multiple organ involvement is highly likely. We suggest that diagnosis of the SFM syndrome is simple, considering the special linear arrangement of sebaceous nevi in cases of SFM syndrome.


Subject(s)
Hamartoma/pathology , Neurocutaneous Syndromes/pathology , Skin Diseases, Genetic/pathology , Child , Female , Hamartoma/history , History, 20th Century , Humans , Neurocutaneous Syndromes/history , Skin Diseases, Genetic/history , Syndrome
16.
Int J Oral Maxillofac Surg ; 32(5): 528-33, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14759113

ABSTRACT

The aim of this study was to assess if the application of rhOP-1 induces accelerated consolidation of the callus in mandibular distraction osteogenesis. In seven adult Wistar rats a bilateral osteotomy of the horizontal ramus of the mandible was performed in the molar region and a custom designed distractor was mounted to the mandible. With a rate of 0.7 mm per day the device was activated bilaterally after the seventh postoperative day. After seven days of distraction two times 50 microg rhOP-1 were injected on two subsequent days directly into the callus. The contralateral side received an injection of placebo solution. The animals were killed four weeks after the end of distraction. A three-point bending test revealed a significantly higher strength of the distracted mandible in the rhOP-1 side (66.3 N vs. 30.4 N, P=0.034, paired t-test). Undecalcified histological sections were examined using microradiography and fluorescence microscopy after sequential intravital polychromic labelling. A continuous bony bridging was seen in all rhOP-1 sites and in none of the control sites. The data indicate that rhOP-1 may be an option to accelerate callus maturation in mandibular distraction osteogenesis.


Subject(s)
Bone Morphogenetic Proteins/physiology , Bone Regeneration/physiology , Bony Callus/physiology , Osteogenesis, Distraction/methods , Osteogenesis/physiology , Transforming Growth Factor beta , Animals , Bone Morphogenetic Protein 7 , Bony Callus/anatomy & histology , Bony Callus/diagnostic imaging , Male , Mandible/surgery , Mandibular Advancement/methods , Radiography , Rats , Rats, Wistar , Recombinant Proteins , Wound Healing/physiology
18.
BMC Surg ; 1: 1, 2001.
Article in English | MEDLINE | ID: mdl-11368798

ABSTRACT

BACKGROUND: Antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE, are an increasing problem world-wide, causing intractable wound infections. Complex phytochemical extracts such as tea tree oil and eucalypt-derived formulations have been shown to have strong bactericidal activity against MRSA in vitro. Polytoxinol (PT) antimicrobial, is the trade name of a range of antimicrobial preparations in solution, ointment and cream form. METHODS: We report the first use of this drug, administered percutaneously, via calcium sulphate pellets (Osteoset,TM), into bone, to treat an intractable MRSA infection of the lower tibia in an adult male. RESULTS AND DISCUSSION: Over a three month period his symptoms resolved with a healing response on x-ray and with a reduced CRP.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Monoterpenes/administration & dosage , Oils, Volatile/administration & dosage , Osteomyelitis/microbiology , Phytotherapy , Plant Preparations/administration & dosage , Staphylococcal Infections/drug therapy , Tea Tree Oil/administration & dosage , Anti-Bacterial Agents/therapeutic use , Drug Combinations , Drug Implants , Eucalyptus , Humans , Male , Methicillin Resistance , Middle Aged , Monoterpenes/therapeutic use , Oils, Volatile/therapeutic use , Osteomyelitis/drug therapy , Plant Preparations/therapeutic use , Staphylococcus aureus/drug effects , Tea Tree Oil/therapeutic use
20.
Ann Plast Surg ; 44(1): 59-64, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10651367

ABSTRACT

The authors emphasize the possible pharmacological enhancement of axonal regeneration using a specific growth factor/ extracellular media incorporated in a biodegradable nonneural nerve conduit material. They investigated the early effects on nerve regeneration of continuous local delivery of nerve growth factor (NGF) and the local incorporation of hyaluronic acid (HA) inside a newly manufactured nerve conduit material from fresh human amnionic membrane. Human amnionic membrane contains important biochemical factors that play a major neurotrophic role in the nerve regeneration process. The process of manufacturing a nerve conduit from fresh human amnionic membrane is described. This nerve conduit system was used in rabbits to bridge a 25-mm nerve gap over 3 months. NGF was released locally, over 28 days, at the distal end of the tube via a system of slow release, and HA was incorporated inside the lumen of the tube at the time of surgery. NGF/HA treatment promoted axonal regeneration across the amnionic tube nerve conduit (8,962 +/- 383 myelinated axons) 45% better than the nontreated amnionic tube group (6,180 +/- 353 myelinated axons). The authors demonstrate that NGF/HA media enhances additional axonal regeneration in the amnionic tube nerve conduit. This result is secondary to the effect of the amnion promoting biochemical factors, in combination with the NGF/HA effect on facilitating early events in the nerve regeneration process.


Subject(s)
Amnion , Hyaluronic Acid/pharmacology , Nerve Growth Factor/pharmacology , Nerve Regeneration , Sciatic Nerve/surgery , Animals , Axons/drug effects , Biodegradation, Environmental , Female , Humans , Male , Prostheses and Implants , Rabbits , Random Allocation , Statistics, Nonparametric
SELECTION OF CITATIONS
SEARCH DETAIL
...